Rockley Photonics Revises Date of First Quarter 2022 Financial Results Release
April 26 2022 - 6:05AM
Business Wire
Rockley Photonics (NYSE: RKLY), a global leader in
photonics-based health monitoring and communications solutions,
today announced that its first quarter 2022 financial results
conference call has been rescheduled to after the market close on
Thursday, May 12, 2022, to allow additional time to prepare its
earnings report. The Company plans to host a conference call that
day at 5:00 p.m. Eastern Time to review its financial results and
business outlook.
“By revising our earnings date, we expect to be able to share
additional information on our earnings call that we are still
reviewing; for example, the preliminary results from our human
study on hydration and a new product shipment milestone,” said Dr.
Andrew Rickman, chairman and chief executive officer of
Rockley.
On the upcoming call, the Company plans to discuss the following
topics –
- Biotpx healthcare biomarker sensing platform, launched two
years early, which includes its wearable band, cloud analytics and
AI, and product samples were shipped to multiple customers in the
first quarter;
- VitalSpex consumer device samples continue to ship to customers
in 2022;
- Timeline for the shipment of its Baseline, including core body
temperature, hydration and blood pressure biomarkers, continues to
be expected in the second half of 2022;
- Timeline for shipment of its Pro, including alcohol, glucose
and lactate, continues to be expected to ship approximately six
months after its Baseline; and
- Rockley’s expanded customer base, which includes companies like
Medtronic, has made the Company less reliant on any one
customer.
The conference call can be accessed by dialing 866-682-6100 from
the United States or +1 862-298-0702 internationally, referencing
Rockley Photonics. A live webcast and replay of the conference call
can be accessed from the investor relations page on Rockley’s
website at investors.rockleyphotonics.com. Following the completion
of the call through 11:59 p.m. ET on May 19, 2022, a telephone
replay will be available by dialing 877-660-6853 from the United
States or +1 201-612-7415 internationally with recording access
code 13729647.
About Rockley Photonics
A global leader in photonics-based health monitoring and
communications solutions, Rockley Photonics is developing a
comprehensive range of photonic integrated circuits and associated
modules, sensors, and full-stack solutions. From next-generation
sensing platforms specifically designed for mobile health
monitoring and machine vision to high-speed, high-volume solutions
for data communications, Rockley is laying the foundation for a new
generation of applications across multiple industries. Rockley
believes that photonics will eventually become as pervasive as
micro-electronics, and it has developed a platform with the power
and flexibility needed to address both mass markets and a wide
variety of vertical applications.
Formed in 2013, Rockley is uniquely positioned to support
hyper-scale manufacturing and address a multitude of high-volume
markets. Rockley has partnered with numerous Tier-1 customers
across a diverse range of industries to deliver the complex optical
systems required to bring transformational products to market.
To learn more about Rockley, visit rockleyphotonics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220425005945/en/
For Rockley Media Debra Raine Rainemakers
Telephone: +1 415-349-7432 Email: rockley-pr@rainemakers.com
Investors Gwyn Lauber Rockley Photonics Telephone: +1
626-995-0001 Email: investors@rockleyphotonics.com
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From Apr 2024 to May 2024
Rockley Photonics (NYSE:RKLY)
Historical Stock Chart
From May 2023 to May 2024